Old Web
English
Sign In
Acemap
>
authorDetail
>
Karolyn Kracht
Karolyn Kracht
Amgen
Pathology
Medicine
Urology
Angiogenesis
Phases of clinical research
3
Papers
141
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of AMG 386 in combination with sunitinib in patients with metastatic renal cell carcinoma (mRCC) in an open-label multicenter phase II study.
2017
Journal of Clinical Oncology
Michael B. Atkins
Alain Ravaud
Gwenaelle Gravis
Kazimierz Drosik
Tomasz Demkow
Piotr Tomczak
Karolyn Kracht
Markus Puhlmann
David M. Weinreich
Show All
Source
Cite
Save
Citations (11)
AMG 386 in Combination With Sorafenib in Patients With Metastatic Clear Cell Carcinoma of the Kidney: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study
2012
Cancer
Brian I. Rini
Cezary Szczylik
Nizar M. Tannir
P. Koralewski
Piotr Tomczak
Andrzej Deptala
Luc Dirix
Mayer Fishman
Rodryg Ramlau
Alain Ravaud
Wojciech Rogowski
Karolyn Kracht
Yu-Nien Sun
Michael B. Bass
Markus Puhlmann
Bernard Escudier
Show All
Source
Cite
Save
Citations (92)
AMG 386 in combination with sorafenib in patients (pts) with metastatic renal cell cancer (mRCC): A randomized, double-blind, placebo-controlled, phase II study.
2011
Journal of Clinical Oncology
Brian I. Rini
Cezary Szczylik
Nizar M. Tannir
P. Koralewski
Piotr Tomczak
Andrzej Deptala
Karolyn Kracht
Yu-Nien Sun
Markus Puhlmann
B. Escudier
Show All
Source
Cite
Save
Citations (38)
1